The findings could lay foundations for cognitive impairment therapy and help improve memory.Continue reading
Category Archives: AZBio News
TGen appoints J. Gregory Caporaso, Ph.D., Professor in its Pathogen and Microbiome Division
Flagstaff, Arizona — July 25, 2023 — The Translational Genomics Research Institute (TGen), part of City of Hope, today announced that J. Gregory Caporaso, Ph.D., has joined the Institute as a Professor in its pathogen and microbiome division located in Flagstaff, more commonly known as TGen North. Continue reading
Unify Medical Announces know-how agreement with Mayo Clinic for Fluorescence-Guided Visualization
Unify Medical, Inc., a privately-held, smart, surgical visualization technology company, announced that, through a know-how agreement with Mayo Clinic to assess and develop clinical applications using Unify’s fluorescence-guided visualization technology.Continue reading
Langham Upgrades Phoenix GMP Warehouse, CRT Expansion
Langham Logistics, an Indiana-based warehousing and transportation company with a focus in life sciences, today announced an adaptation of the second half of its Arizona building to GMP controlled room space. More than 9,000 newly-converted controlled room temperature (CRT) pallet positions opened for full operations on June 1st to serve the West Coast’s cold chain warehousing and distribution demands.Continue reading
IdeaFunding Returns to TENWEST Impact Festival in 2023 to Showcase Innovation and Entrepreneurship – Applications Launch for Pitch Competition with over $70,000 in Prizes
July 24, 2023 (Tucson, Ariz.) – Applications for the 2023 IdeaFunding competition are live and startups can submit applications before August 28, 2023. IdeaFunding is Southern Arizona’s largest and longest entrepreneurial conference and pitch competition, where this year over $70,000 in prize funding will be awarded to Arizona companies. IdeaFunding is co-led by Startup Tucson and the University of Arizona Center for Innovation (UACI) and presented by the Arizona Commerce Authority. Continue reading
Nectero Medical Receives FDA Clearance of IND Application to Initiate Phase II/III Clinical Trial of Nectero EAST® System for Treatment of Small- to Mid-Sized Abdominal Aortic Aneurysms
Pivotal trial to be conducted at multiple sites, primarily in the U.S., using novel single-use, endovascular system comprised of a dual-balloon delivery catheter and stabilizer mixture containing pentagalloyl glucoseContinue reading
Erroneous genetic sequences identified for the first time in specific cells of ALS and frontotemporal dementia patients
Gene splicing defect known as “cryptic exons” detected using single-nuclei RNA sequencingContinue reading
The Foundation for Angelman Syndrome Therapeutics to Contribute Data to C-Path’s RDCA-DAP, Accelerating Neurological Disease Research and Therapeutic Development
TUCSON, Ariz., July 19, 2023 — Critical Path Institute (C-Path) announced today that the Foundation for Angelman Syndrome Therapeutics (FAST), a nonprofit organization dedicated to finding a cure for this genetic disorder, have contributed data from the Global Angelman Syndrome Registry to the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), managed by C-Path.Continue reading
Ivy Brain Tumor Center Opens Novel Clinical Trial to Test Direct-to-Tumor Drug Delivery Method
- Innovative technique aims to bypass the most difficult barrier in brain cancer treatment
Aqualung Therapeutics Receives FDA Clearance To Proceed With the P2A PUERTA Study in Moderate/Severe Acute Respiratory Distress Syndrome (ARDS) Patients
- Aqualung Therapeutics will initiate moderate/severe ARDS patient recruitment for U.S. and Australia hospital sites in August 2023.
- Aqualung appoints Jackson Streeter MD to their board of directors bringing expertise to Aqualung to support advancing of ALT-100 mAb as a novel therapeutic for inflammatory and fibrotic diseases (ARDS, radiation-induced lung fibrosis, pulmonary arterial hypertension)